▲ Up
09:19 26-11-2015
MAIN АКИpress CA-News
About us On-line subscription
Drug to crack resistant TB

Bishkek (AKIpress) - doctor-x-ray Florian von Groote-Bidlingmaier, medical director of TASK Applied Science, a research unit collaborating with Stellenbosch University, told doctors yesterday about trials of new drugs that might offer a lifeline to patients with drug-resistant TB, Times Live reported.

He was speaking at the World TB Day Symposium, convened by the National Institute for Communicable Diseases, in Johannesburg.

Half-a-million South Africans contract TB every year and one in 25 is likely to develop a form of the disease resistant to treatment. Drug-resistant TB kills at least one in five of the people who contract it.

Most TB drugs have been in use for at least 50 years, Von Groote-Bidlingmaier said, but the development of a new medicine took many years and could cost as much as 10 billion rand ($920.3 million).

It can be years before patients gain access to a new medicine. For example, the drug bedaquiline was developed in 2005 but almost 10 years later it is available to only 200 patients in South Africa in a monitored program with strict eligibility criteria.

Von Groote-Bidlingmaier said that delamanid, conditionally approved by the European Medicines Agency recently, was being tested at three sites in South Africa and abroad. The current trials, if successful, are the last step before the drug is registered.

“TB is not treated with a single drug. There is a need for further trials to test new drugs in combination to see if we can find a better treatment regimen.”

South Africa is the world leader in the exploitation of the GeneXpert machine to detect TB much more quickly. But a study has shown that, though detection has improved, patients are no more likely to start and see their treatment through to completion.

TASK Applied Science performs clinical trials in tuberculosis (TB) in Cape Town, South Africa. TASK can provide assistance to efficiently conduct studies for diagnosis, treatment or prevention of tuberculosis.

13:01 25.03.2014
17:45 Tajik Interior Ministry detains three suspected drug traffickers17:21 New children library opens in Ulaanbaatar17:17 Kyrgyzstan uses 80% of international Internet traffic, 20% of domestic traffic – expert17:17 New building of school completed in Osh17:14 Bishkek combined heat and power plant to produce 777.5 million kWh of electricity in Q1 201617:09 Buses created by Mongolian engineers put into public use16:56 Russia deploying advanced anti-aircraft missile systems to Syria as Turkey downs Russian jet, killing 1 pilot, 2nd rescued16:49 82 Mongolians investigated under drug charges16:42 Parliament of Kazakhstan approves draft state budget 2016-201816:39 EU urges Uzbekistan to ease restrictions on press and free all imprisoned human rights defenders16:33 Speaker of Mongolian Parliament meets delegation from Buryatia16:21 National Bank of Kyrgyzstan sells $15.42 million to support som rate16:19 Interior Ministry supports proposal to revoke citizenship of those who participate in fighting in Syria16:16 Delegation of Kyrgyzstan attends health cooperation seminar in China15:57 OSCE media freedom representative welcomes new law on access to information in Kazakhstan, but says drawbacks still exist15:37 Kyrgyz citizens participating in international trade fair in India15:34 Dancesport tournament starts tomorrow in Mongolia15:34 World Bank approves $16.11 million for improvement of forest ecosystem management15:17 National Super League starts this week in Mongolia15:02 Number of Kyrgyz migrants in Russia ceases to decline and even increases, number of Tajik, Uzbek migrants decreases
° C
° C
° C
° C
° C
exchange rates

© AKIpress News Agency - 2001-2015. All rights reserved
Republication of any material is prohibited without a written agreement with AKIpress News Agency. Any citation must be accompanied by a hyperlink to www.akipress.com.
Our address:
Moskovskaya str. 189, Bishkek, the Kyrgyz Republic
e-mail: english@akipress.org, akipressenglish@gmail.com;
Tel/Fax: +996(312)90-07-75